Hongkou Capital is a New York-based financial services firm specializing in venture capital investments. Founded in 2020, the company focuses on early to mid-stage funding rounds, particularly Series B investments. Hongkou Capital's portfolio spans diverse sectors, including technology and healthcare.
Notable portfolio companies include Amionx and Day Zero Diagnostics, with the latter having raised $21 million in total funding. Founded by Peter Zhou, Hongkou Capital aims to support innovative startups with growth potential. The firm's investment strategy likely involves providing both capital and strategic guidance to help portfolio companies scale and succeed in their respective markets.
Hongkou Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Current Portfolio Count2
Top Investment Stages
Series B2 (100.0%)
Stage Mix
Series B 100%
Concentration shown as share of disclosed investments by stage.
